SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-13-003611
Filing Date
2013-03-29
Accepted
2013-03-29 07:32:33
Documents
5
Period of Report
2013-05-07
Effectiveness Date
2013-03-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2214056zdef14a.htm DEF 14A 909439
2 G463432.JPG g463432.jpg GRAPHIC 12470
3 G404820.JPG g404820.jpg GRAPHIC 9567
4 G17442BGI001.GIF g17442bgi001.gif GRAPHIC 56315
5 G17442BGI002.GIF g17442bgi002.gif GRAPHIC 48001
  Complete submission text file 0001047469-13-003611.txt   1085146
Mailing Address 550 HILLS DRIVE BEDMINSTER NJ 07921
Business Address 550 HILLS DRIVE BEDMINSTER NJ 07921 (908) 450-5300
NPS PHARMACEUTICALS INC (Filer) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-23272 | Film No.: 13726182
SIC: 2836 Biological Products, (No Diagnostic Substances)